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a b s t r a c t
Although the most feared cardiac manifestation in cardiac sarcoidosis is the onset of ventricular
arrhythmia, some patients may present with supraventricular arrhythmias. We present a rare case of
cardiac sarcoidosis associated with double tachycardia manifesting as atrial ﬂutter and ventricular
tachycardia.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Sarcoidosis is a multisystem granulomatous disease of unknown
etiology. In autopsy studies, cardiac involvement has been reported
in 40–50% of patients [1].
In cardiac sarcoidosis, ventricular arrhythmias are the most
well-known and feared cardiac manifestation, but some of these
patients have supraventricular arrhythmias. We present a rare case
of cardiac sarcoidosis associated with double tachycardia mani-
festing as atrial ﬂutter and ventricular tachycardia.
2. Case report
The patient was a 60-year-old man who experienced palpita-
tions for the past 6 months. During a medical clinic visit, atrial
tachycardia (AT) was suggested on 12-lead electrocardiography
(ECG) with a heart rate of 75 beats/min and 3–5:1 atrioventricular
conduction. The Holter ECG recorded the AT and frequent
ventricular tachycardia (VT) episodes of 3–18 beats (Fig. 1A).
Because the AT and VT were drug-refractory, he was referred to
our hospital for an electrophysiologic study and catheter ablation.
Echocardiography revealed dilatation of the right and left atria
and a mildly reduced left ventricular (LV) systolic function with
an aneurysm on the basal posterior LV wall. Blood examination
results were normal, including angiotensin converting enzyme
levels. Chest radiography and computed tomography (CT) revealed
cardiac dilatation, but lung parenchyma lymph nodes were not
swollen. Contrast-enhanced magnetic resonance imaging (MRI)
revealed delayed enhancement of the aneurysm. The coronary
angiogram was normal. The 18F-ﬂuorodeoxyglucose positron
emission tomography (PET)–CT revealed extensive hypermetabolic
activity in the basal posterior septum and LV posterolateral wall.
Together, these ﬁndings suggested the presence of cardiac sarcoi-
dosis. A voltage map obtained during the electrophysiologic study
revealed low-voltage areas in the high anterior and lateral por-
tions of the right atrium. Atrial activation during the AT occurred
in the counterclockwise direction around the tricuspid valve.
Pacing from the cavotricuspid isthmus exhibited concealed
entrainment; therefore, typical atrial ﬂutter (AFL) was diagnosed.
The AFL was terminated by ablation of the cavotricuspid isthmus.
Thereafter, sustained monomorphic VT, with the morphology of a
right-bundle branch block and superior axis, was induced by
programmed right ventricular stimulation. An LV voltage map
obtained during sinus rhythm revealed a low-voltage area with
delayed potentials in the posterior LV aneurysm. The activation
map during VT revealed a focal reentrant pattern with a clockwise
rotation in the posterior LV aneurysm, where a mid-diastolic
potential was recorded (Fig. 1B). Pacing from this site demon-
strated concealed entrainment (Fig. 1C). These ﬁndings strongly
suggested that the mechanism of the VT was reentry. The VT
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terminated 7.8 s after commencing radiofrequency ablation, and
was no longer inducible by programmed ventricular pacing.
3. Discussion
Ventricular arrhythmias are the most well-known and feared
cardiac manifestations of cardiac sarcoidosis. However, AFL is
relatively rare, with a reported prevalence of 5% [2]. In this case,
MRI and 18F-FDG PET–CT strongly supported a diagnosis of cardiac
sarcoidosis, and the patient had typical AFL; however, the mor-
phology showed an atypical AT on ECG. This case of cardiac
sarcoidosis was rare, not only because of the supraventricular
tachyarrhythmia but also because of the double tachycardias, i.e.,
simultaneous VT and AFL. The etiology of these tachyarrhythmias
remains unknown. Previous cases of cardiac sarcoidosis with ATs
were associated with systemic hypertension, diastolic dysfunction,
and LA enlargement. Further, atrial ﬁbrillation was the most
common clinical manifestation [2]. Their results suggested that
ATs could be related to atrial dilatation secondary to LV dysfunc-
tion. In fact, arrhythmias may be less commonly caused by direct
granulomatous involvement of the atria [3–5]. However, this case
had a typical AFL with right-sided dominant atrial dilatation and
scar formation, suggesting a different mechanism. For example,
noncaseating granulomas may favor involvement of speciﬁc
regions of the septum and basal ventricle, but eventually become
widespread, and may even involve the atria as well. Although a
pathological examination failed to ﬁnalize the underlying mechan-
ism of these double tachyarrhythmias, this case highlights the fact
that in some cases of cardiac sarcoidosis, the ventricles as well as
the atria may be involved in producing arrhythmias of not only a
ventricular but also an atrial origin.
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Fig. 1. Atrial tachycardia (red arrow) with 3:1 atrioventricular conduction and 18 beats of ventricular tachycardia simultaneously observed on Holter electrocardiography are
shown (A). The three-dimensional activation map (inferior view) obtained during ventricular tachycardia (VT) (B). Concealed entrainment observed during VT when pacing
was performed at the site of the mid-diastolic potential (DP) (C). The yellow arrows indicate a DP.
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